1. Home
  2. DRMA vs AVGR Comparison

DRMA vs AVGR Comparison

Compare DRMA & AVGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • AVGR
  • Stock Information
  • Founded
  • DRMA 2014
  • AVGR 2007
  • Country
  • DRMA United States
  • AVGR United States
  • Employees
  • DRMA N/A
  • AVGR N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • AVGR Medical/Dental Instruments
  • Sector
  • DRMA Health Care
  • AVGR Health Care
  • Exchange
  • DRMA Nasdaq
  • AVGR Nasdaq
  • Market Cap
  • DRMA 2.2M
  • AVGR 2.6M
  • IPO Year
  • DRMA 2021
  • AVGR 2015
  • Fundamental
  • Price
  • DRMA $1.33
  • AVGR $0.60
  • Analyst Decision
  • DRMA Strong Buy
  • AVGR Strong Buy
  • Analyst Count
  • DRMA 1
  • AVGR 1
  • Target Price
  • DRMA $6.00
  • AVGR $5.00
  • AVG Volume (30 Days)
  • DRMA 230.6K
  • AVGR 6.7M
  • Earning Date
  • DRMA 11-13-2024
  • AVGR 11-07-2024
  • Dividend Yield
  • DRMA N/A
  • AVGR N/A
  • EPS Growth
  • DRMA N/A
  • AVGR N/A
  • EPS
  • DRMA N/A
  • AVGR N/A
  • Revenue
  • DRMA N/A
  • AVGR $7,262,000.00
  • Revenue This Year
  • DRMA N/A
  • AVGR N/A
  • Revenue Next Year
  • DRMA N/A
  • AVGR $93.49
  • P/E Ratio
  • DRMA N/A
  • AVGR N/A
  • Revenue Growth
  • DRMA N/A
  • AVGR N/A
  • 52 Week Low
  • DRMA $1.00
  • AVGR $0.39
  • 52 Week High
  • DRMA $8.66
  • AVGR $5.45
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 51.81
  • AVGR 44.72
  • Support Level
  • DRMA $1.30
  • AVGR $0.55
  • Resistance Level
  • DRMA $1.48
  • AVGR $0.83
  • Average True Range (ATR)
  • DRMA 0.12
  • AVGR 0.13
  • MACD
  • DRMA 0.00
  • AVGR -0.02
  • Stochastic Oscillator
  • DRMA 49.66
  • AVGR 13.89

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About AVGR Avinger Inc.

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

Share on Social Networks: